Scholars Central

Review articlePublished 10 May 2022

Orexin Receptor Antagonists: Alternative Treatment of Primary Insomnia

Authors: Hani Raoul Khouzam

Neurology and Neurorehabilitation

Volume 4 · Issue 2 · Pages 16–19

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Pharmacological agents currently available for the treatment of primary insomnia have demonstrated limited long-term efficacy and problematic side effects. The purpose of this review is to highlight the concerns surrounding the most widely used medications that are commonly prescribed for the management of primary insomnia, and to summarize the mechanism of action and beneficial effects of the orexin receptor antagonists suvorexant, lemborexant and daridorexant as alternative therapeutic interventions for the management of primary insomnia.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Neurology and Neurorehabilitation.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalNeurology and Neurorehabilitation
  • SubjectNeuroscience & Neurology
  • BylineArticles whose byline prints “Hani Raoul Khouzam”